ATG vs thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia

Matched-related bone marrow transplantation (BMT) may cure >80% of low-risk children with severe thalassemia (ST). Very long-term follow-up studies have shown how the standard busulfan-cyclophosphamide (BuCy) regimen may be associated with normalization of health-related quality of life, no secon...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood Adv
Autores principales: Faulkner, Lawrence, Uderzo, Cornelio, Khalid, Sadaf, Marwah, Priya, Soni, Rajpreet, Yaqub, Naila, Amanat, Samina, Fatima, Itrat, Gilani, Sarah Khan, Zahra, Tatheer, Ramprakash, Stalin, Gooneratne, Lallindra, Dissanayake, Ruwangi, Williams, Senani, Rathnayake, Wasantha, Srinivas, Reshma, Sedai, Amit, Kumari, Ankita, Parmar, Lailith, Dhanya, Rakesh, Agarwal, Rajat Kumar
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2017
Materias:
Transplantation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5727808/
https://ncbi.nlm.nih.gov/pubmed/29296723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2016004119
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares